A new Czech study (Cell Reports, 2025): SARS-CoV-2 can trigger Epstein-Barr virus (EBV) reactivation - and in some people, that leads to long-term lung damage in long COVID.
Up to 70% of SARS-CoV-2 infected have reduced organ function for 4 months or more after infection, which leads to an increased risk of developing chronic diseases in e.g. lungs, kidneys and the cardiovascular system.
“Even though the etiology of COVID-19 is complex and there are multiple factors involved, decreased organ function has been associated with mitochondrial dysfunction for both the acute phase and post-acute phase of COVID”
